Skip to main content

Familial Hypercholesterolaemia

Question for Department of Health

UIN 68839, tabled on 23 March 2017

To ask the Secretary of State for Health, if he will estimate the potential (a) medium and (b) long-term cost savings to the NHS of the use of genetic cascade testing to identify and treat familial hypercholesterolaemia.

Answered on

30 March 2017

The current National Institute for Health and Care Excellence guidance recommends genetic cascade testing for familial hypercholesterolaemia as highly cost effective. This guidance is currently under review, due to be issued in May 2017, and will take into account the latest changes to the costs of drugs and genetic tests in its revised economic modelling.